<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_2020_03_20_999730v3/results/search/disease/results.xml">
  <result pre="from FDA-approved drugs | bioRxiv Abstract COVID-19 is an emerging" exact="infectious disease" post="and was recently declared as a pandemic by WHO."/>
  <result pre="options for patients with COVID-19. Introduction COVID-19 is an emerging" exact="infectious disease" post="caused by a novel coronavirus, SARS-CoV-2 1 . Although"/>
  <result pre="than niclosamide. It is an inhaled corticosteroid used to treat" exact="asthma" post="and allergic rhinitis 11 . A recent report by"/>
  <result pre="It is an inhaled corticosteroid used to treat asthma and" exact="allergic rhinitis" post="11 . A recent report by Matsuyama et al."/>
  <result pre="is an inhaled corticosteroid used to treat asthma and allergic" exact="rhinitis" post="11 . A recent report by Matsuyama et al."/>
  <result pre="in patients with COVID-19. Intriguingly, an underlying mechanism for the" exact="suppression" post="of viral infection by ciclesonide has been revealed by"/>
  <result pre="Co-first authors References 1. ↵ Zhou, P. et al. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="CrossRef 8. ↵ Wu, C. J. et al. Inhibition of" exact="severe acute respiratory syndrome" post="coronavirus replication by niclosamide. Antimicrob. Agents Chemother. ( 2004)"/>
 </snippets>
</snippetsTree>
